MX9205215A - Procedimiento novedoso para la preparacion de 1,4-dihidropiridina 4-substituida - Google Patents
Procedimiento novedoso para la preparacion de 1,4-dihidropiridina 4-substituidaInfo
- Publication number
- MX9205215A MX9205215A MX9205215A MX9205215A MX9205215A MX 9205215 A MX9205215 A MX 9205215A MX 9205215 A MX9205215 A MX 9205215A MX 9205215 A MX9205215 A MX 9205215A MX 9205215 A MX9205215 A MX 9205215A
- Authority
- MX
- Mexico
- Prior art keywords
- substituted
- reaction
- dihydropyridine
- preparation
- novel procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75902691A | 1991-09-13 | 1991-09-13 | |
US07/920,701 US5310917A (en) | 1991-09-13 | 1992-07-28 | Process for the preparation of 4-substituted-1,4-dihydropydrines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9205215A true MX9205215A (es) | 1993-03-01 |
Family
ID=27116618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9205215A MX9205215A (es) | 1991-09-13 | 1992-09-11 | Procedimiento novedoso para la preparacion de 1,4-dihidropiridina 4-substituida |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0534520B1 (es) |
JP (1) | JPH0751562B2 (es) |
CN (1) | CN1070907A (es) |
AT (1) | ATE150456T1 (es) |
AU (1) | AU654387B2 (es) |
CA (1) | CA2077919A1 (es) |
DE (1) | DE69218330T2 (es) |
DK (1) | DK0534520T3 (es) |
ES (1) | ES2101027T3 (es) |
GR (1) | GR3022877T3 (es) |
IL (1) | IL103010A (es) |
LV (1) | LV12072B (es) |
MX (1) | MX9205215A (es) |
NZ (1) | NZ244130A (es) |
WO (1) | WO1993006082A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4342196A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Neue 4-Phenyl-substituierte 1,4-Dihydropyridine |
DK0657432T3 (da) | 1993-12-10 | 2003-07-07 | Bayer Ag | Phenylsubstituerede 1,4-dihydropyridiner med cerebral aktivitet |
DE4423445A1 (de) * | 1994-07-05 | 1996-01-11 | Bayer Ag | Katalysatorverfahren zur Herstellung von Nifedipin |
US5668151A (en) * | 1995-06-07 | 1997-09-16 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: piperidine derivatives |
US5554621A (en) * | 1995-06-07 | 1996-09-10 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
US5977369A (en) * | 1995-12-28 | 1999-11-02 | Napp Technologies, Inc. | Process to prepare dihydropyridine and derivatives thereof |
IT1283793B1 (it) * | 1996-08-23 | 1998-04-30 | Lusochimica Spa | Processo per la preparazione di diidropiridine |
US5889016A (en) * | 1997-06-26 | 1999-03-30 | Bristol-Myers Squibb Company | Dihydropyrimidone derivatives as NPY antagonists |
HUP9900353A3 (en) * | 1999-02-15 | 2002-01-28 | Egis Gyogyszergyar Nyilvanosan | Process for producing asymmetric esters of 1,4-dihydropyridine-dicarboxylic acids |
CA2377698A1 (en) | 1999-06-21 | 2000-12-28 | Bristol-Myers Squibb Company | Dihydropyrazine derivatives as npy antagonists |
WO2002053538A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Amlodipine fumarate |
US6653481B2 (en) | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
WO2002053540A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Aspartate derivative of amlodipine as calcium channel antagonist |
CA2433193C (en) | 2000-12-29 | 2006-01-31 | Pfizer Limited | Amide derivative of amlodipine |
MXPA03005882A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
MXPA03005885A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Procedimiento para fabricar maleato de amlodipina. |
GB2371862B (en) | 2000-12-29 | 2004-07-14 | Bioorg Bv | Reference standards for determining the purity or stability of amlodipine maleate and processes therefor |
ES2254495T4 (es) | 2000-12-29 | 2007-06-16 | Pfizer Limited | Hemimaleato de amlodipina. |
WO2010039977A2 (en) | 2008-10-01 | 2010-04-08 | Amira Pharmaceuticals, Inc. | Heteroaryl antagonists of prostaglandin d2 receptors |
CN101613280B (zh) * | 2009-05-13 | 2012-10-17 | 合肥立方制药股份有限公司 | 非洛地平合成中间体2,3-二氯亚苄基乙酰乙酸甲酯的制备方法 |
CN101987833B (zh) * | 2009-08-04 | 2014-07-30 | 北京利乐生制药科技有限公司 | 尼伐地平晶型及其制备方法 |
WO2012123966A1 (en) | 2011-03-04 | 2012-09-20 | Arch Pharmalabs Limited | Process for the preparation of 4 -substituted -1, 4-dihydropyridines |
CN102285911B (zh) * | 2011-07-12 | 2015-06-17 | 绍兴文理学院 | 非洛地平的制备方法 |
CN102304079B (zh) * | 2011-09-29 | 2013-09-25 | 合肥立方制药股份有限公司 | 一种非洛地平环合反应液直接水析纯化方法 |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA863578B (en) * | 1985-06-21 | 1987-02-25 | Hoffmann La Roche | Dihydropyridine derivatives |
US4780538A (en) * | 1986-02-12 | 1988-10-25 | Merck & Co., Inc. | Process for 1,4-dihydropyridine compounds using a titanamine catalyst |
FR2596760B1 (fr) * | 1986-04-02 | 1988-12-09 | Sori Soc Rech Ind | Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique |
JPH02149563A (ja) * | 1988-11-30 | 1990-06-08 | Nisshin Flour Milling Co Ltd | 2−ハロエトキシカルボニル基を含有する1,4−ジヒドロピリジン誘導体の製造法 |
JPH04211060A (ja) * | 1990-03-07 | 1992-08-03 | Tokawa Tetsuo | 2,6−ジメチル−4−(m−ニトロフェニル)−1,4−ジヒドロピリジン−3,5−ジカルボン酸−3−メチルエステル−5−β−(N−ベンジル−N−メチルアミノ)エチルエステルの新規製造方法 |
DE4011695A1 (de) * | 1990-04-11 | 1991-10-17 | Bayer Ag | Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung |
-
1992
- 1992-08-26 WO PCT/US1992/007220 patent/WO1993006082A1/en unknown
- 1992-08-28 NZ NZ244130A patent/NZ244130A/en unknown
- 1992-09-01 IL IL10301092A patent/IL103010A/en not_active IP Right Cessation
- 1992-09-05 DE DE69218330T patent/DE69218330T2/de not_active Expired - Fee Related
- 1992-09-05 EP EP92202690A patent/EP0534520B1/en not_active Expired - Lifetime
- 1992-09-05 ES ES92202690T patent/ES2101027T3/es not_active Expired - Lifetime
- 1992-09-05 AT AT92202690T patent/ATE150456T1/de not_active IP Right Cessation
- 1992-09-05 DK DK92202690.1T patent/DK0534520T3/da active
- 1992-09-07 JP JP4238429A patent/JPH0751562B2/ja not_active Expired - Fee Related
- 1992-09-10 CA CA002077919A patent/CA2077919A1/en not_active Abandoned
- 1992-09-11 AU AU23552/92A patent/AU654387B2/en not_active Ceased
- 1992-09-11 CN CN92110385.9A patent/CN1070907A/zh active Pending
- 1992-09-11 MX MX9205215A patent/MX9205215A/es not_active IP Right Cessation
-
1997
- 1997-03-20 GR GR970400486T patent/GR3022877T3/el unknown
-
1998
- 1998-03-06 LV LVP-98-44A patent/LV12072B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2355292A (en) | 1993-03-18 |
DE69218330T2 (de) | 1997-09-18 |
ATE150456T1 (de) | 1997-04-15 |
EP0534520A3 (en) | 1993-05-05 |
GR3022877T3 (en) | 1997-06-30 |
AU654387B2 (en) | 1994-11-03 |
ES2101027T3 (es) | 1997-07-01 |
LV12072B (en) | 1998-09-20 |
EP0534520B1 (en) | 1997-03-19 |
IL103010A0 (en) | 1993-02-21 |
DK0534520T3 (da) | 1997-09-08 |
EP0534520A2 (en) | 1993-03-31 |
JPH05221984A (ja) | 1993-08-31 |
WO1993006082A1 (en) | 1993-04-01 |
NZ244130A (en) | 1994-10-26 |
JPH0751562B2 (ja) | 1995-06-05 |
CA2077919A1 (en) | 1993-03-14 |
CN1070907A (zh) | 1993-04-14 |
LV12072A (lv) | 1998-06-20 |
IL103010A (en) | 1996-10-31 |
DE69218330D1 (de) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9205215A (es) | Procedimiento novedoso para la preparacion de 1,4-dihidropiridina 4-substituida | |
CA2106200A1 (en) | Stereoselective preparation of substituted piperidines | |
JPS55301A (en) | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation | |
JPS5762257A (en) | 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt | |
YU89392A (sh) | Novi postupak za dobijanje 4-supstituisanih-1,4-dihidropiridina | |
DK209289A (da) | Fremgangsmaade til fremstilling af indol-3-carboxylsyreestere af trans-hexahydro-8-hydroxy-2,6-methano-2h-quinolin-3(4h)-on | |
DK300489D0 (da) | Fremgangsmaade til fremstilling af phenyleddikesyrederivater | |
EP0207674A3 (en) | 1,4-dihydropyridine derivatives, their preparation and their pharmaceutical use | |
DK0531845T3 (da) | Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester | |
EP0202625A3 (en) | Process for the preparation of 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-(n-benzyl-n-methylamino)-ethyl ester 5-methyl ester and its hydrochloride salt | |
KR870008872A (ko) | 광활성 화합물의 제조방법 | |
SE8900813L (sv) | Foerfarande foer framstaellning av dihydropyridinderivat | |
DE3777464D1 (de) | Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung. | |
DE3781783D1 (de) | N-alkyl-derivate von 2-amino-6,7-dimethoxytetralin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen mit antihypertensiver wirkung. | |
AU6713887A (en) | Methionine-substituted 1, 4-dihydropyridines, process for the preparation and their use | |
ATE75739T1 (de) | Verfahren zur herstellung von dibenzothiepinderivaten. | |
RU1828464C (ru) | Способ получени диметилового эфира 1,4-дигидро-2,6-диметил-4-/2 @ -нитрофенил/-пиридин-3,5-дикарбоновой кислоты | |
NZ217732A (en) | Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester | |
RO95927A2 (ro) | Derivati de 2,2,6,6-tetrametilpiperidina si procedeu de preparare a acestora | |
ES537914A0 (es) | Procedimiento de obtencion del dimetil ester del acido 1,4-dihidro-2,6-dimetil-4-(2-nitrofenil)-3,5-piridindicarboxilico | |
ES2078288T3 (es) | Isomeros de 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-5-nitropiridina-3-carboxilato de 1-azabiciclo(2.2.2)oct-3-ilo. | |
EP0167068A3 (en) | Isopropyl-2û2-(3-trifluoromethylphenoxy)ethyl¨ester of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylic acid, process for its preparation, and its use as a medicine | |
ES8706118A1 (es) | Procedimiento para la preparacion de derivados de 1,4-dihi- dropiridina | |
NO881709D0 (no) | Fremgangsmaate ved fremstilling av nye dihydropyridinderivater. | |
EP0311053A3 (en) | Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |